The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

J.L. Molinuevo; K. Blennow; B Dubois; S. Engelborghs; P. Lewczuk; A. Perret-Liaudet; C.E. Teunissen; L. Parnetti

doi:10.1016/j.jalz.2014.03.003

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

J.L. Molinuevo, K. Blennow, B Dubois, S. Engelborghs, P. Lewczuk, A. Perret-Liaudet, C.E. Teunissen, L. Parnetti

Clinical chemistry

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	808-817
Journal	Alzheimers & Dementia
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/j.jalz.2014.03.003
Publication status	Published - 2014

Cite this

Molinuevo, J. L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret-Liaudet, A., ... Parnetti, L. (2014). The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers & Dementia, 10(6), 808-817. https://doi.org/10.1016/j.jalz.2014.03.003

@article{204c710046754dfdbcb05931375042c7,

title = "The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative",

author = "J.L. Molinuevo and K. Blennow and B Dubois and S. Engelborghs and P. Lewczuk and A. Perret-Liaudet and C.E. Teunissen and L. Parnetti",

year = "2014",

doi = "10.1016/j.jalz.2014.03.003",

language = "Undefined/Unknown",

volume = "10",

pages = "808--817",

journal = "Alzheimers & Dementia",

issn = "1552-5260",

publisher = "Elsevier",

number = "6",

}

Molinuevo, JL, Blennow, K, Dubois, B, Engelborghs, S, Lewczuk, P, Perret-Liaudet, A, Teunissen, CE & Parnetti, L 2014, 'The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative', Alzheimers & Dementia, vol. 10, no. 6, pp. 808-817. https://doi.org/10.1016/j.jalz.2014.03.003

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. / Molinuevo, J.L.; Blennow, K.; Dubois, B; Engelborghs, S.; Lewczuk, P.; Perret-Liaudet, A.; Teunissen, C.E.; Parnetti, L.

In: Alzheimers & Dementia, Vol. 10, No. 6, 2014, p. 808-817.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

AU - Molinuevo, J.L.

AU - Blennow, K.

AU - Dubois, B

AU - Engelborghs, S.

AU - Lewczuk, P.

AU - Perret-Liaudet, A.

AU - Teunissen, C.E.

AU - Parnetti, L.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.jalz.2014.03.003

DO - 10.1016/j.jalz.2014.03.003

M3 - Article

C2 - 25150736

VL - 10

SP - 808

EP - 817

JO - Alzheimers & Dementia

JF - Alzheimers & Dementia

SN - 1552-5260

IS - 6

ER -

Access to Document

10.1016/j.jalz.2014.03.003